AST Lab Test: How Nutrition and Fasting Change Your Results
At a glance
- Standard normal range / 10 to 40 U/L (lab-dependent; women's upper limit typically 35 U/L)
- Optimal / functional target / 10 to 26 U/L
- Fasting requirement / 8 to 12 hours preferred for most accurate baseline
- Life-stage note / Oral contraceptives and estrogen therapy can lower AST; values rise postpartum and during strenuous exercise
- Key ratio / AST:ALT ratio <1 suggests fatty liver; >2 suggests alcoholic hepatitis
- Pregnancy / AST rises modestly in normal third trimester; marked elevation may indicate HELLP syndrome
- Women-specific confounder / Vigorous exercise raises AST from muscle (not liver) within 24 to 48 hours
What Is AST and Why Does It Matter for Women
AST is an enzyme found in liver cells, heart muscle, skeletal muscle, red blood cells, and the kidneys. When any of those tissues are stressed or damaged, AST leaks into the bloodstream. Doctors order it most often alongside ALT (alanine aminotransferase) because the ratio of the two tells a more precise story than either number alone.
For women specifically, AST has a few quirks that are underappreciated in standard clinical practice. Sex-based reference intervals are not universal across labs, and some laboratories still report a single upper limit of normal that was derived from predominantly male cohorts. A 2017 analysis published in the American Journal of Gastroenterology confirmed that the upper limit of normal for AST in women should be approximately 10 to 20 percent lower than the male cutoff, meaning your result can be flagged "normal" by the lab yet still reflect early liver stress.
Why AST Is Never Interpreted Alone
The AST:ALT ratio carries more diagnostic weight than either value in isolation. An AST:ALT ratio persistently below 1 points toward non-alcoholic fatty liver disease (NAFLD), which now affects roughly 25 percent of the global adult population and is increasingly recognized in women with PCOS and insulin resistance. A ratio above 2, particularly when both values are elevated, raises concern for alcoholic hepatitis. Ratio above 3 with a low platelet count can signal cirrhosis.
Your result also needs to be interpreted against your clinical context: recent exercise, what you ate the day before, your cycle phase, your thyroid status, and whether you take supplements or medications.
AST Normal Range vs. Optimal Range: What the Numbers Mean for You
Most US hospital laboratories report an AST normal range of 10 to 40 U/L, but the upper limit of normal differs by sex. Women's upper limit is commonly cited at 10 to 35 U/L. If your lab uses a non-sex-stratified reference interval and your result is 36 to 40 U/L, ask your clinician to compare it against a women-specific cutoff before assuming everything is fine.
The Functional or "Optimal" Target
Longevity and functional medicine clinicians often use a tighter target. The commonly cited optimal range is 10 to 26 U/L for women not in pregnancy. This narrower band is not yet codified in a major society guideline, but it aligns with data from large epidemiological cohorts showing that AST values in the upper third of the "normal" range correlate with higher rates of metabolic dysfunction. A 2022 Korean cohort study in BMC Gastroenterology covering 367,000 adults found that AST above 26 U/L was independently associated with elevated risk of NAFLD progression even when values stayed within the laboratory normal range.
When Low AST Is a Problem
Values below 10 U/L are uncommon but can indicate severe vitamin B6 (pyridoxine) deficiency, because AST depends on B6 as a cofactor. Very low values also appear in late-stage liver failure when so few functional hepatocytes remain that there is nothing left to release. A single very low value in isolation is rarely actionable, but a trend downward alongside other signs of nutritional deficiency warrants evaluation.
How Fasting Affects Your AST Result
The Case for 8 to 12 Hours of Fasting
AST does not spike as dramatically after a meal as, say, triglycerides do. Still, postprandial fat absorption stimulates the gut and can transiently shift hepatic enzyme activity. Most clinical laboratories and the American Association for Clinical Chemistry (AACC) recommend at least 8 hours of fasting before a comprehensive metabolic panel that includes liver enzymes. An overnight fast of 10 to 12 hours provides the cleanest baseline.
Prolonged Fasting Can Also Raise AST
Counterintuitively, fasting beyond 24 to 48 hours can raise AST. Extended calorie restriction triggers mild hepatocyte stress and autophagy-related enzyme release. A 2020 study in Cell Metabolism documented transient rises in liver enzymes during multi-day fasting protocols, with values returning to baseline within 48 to 72 hours of refeeding. If you practice alternate-day fasting or extended fasting and your AST comes back mildly elevated, timing matters. Ideally, draw blood at least two days after your last prolonged fast.
Meal Composition and Hepatic Enzyme Flux
High-fat, high-fructose meals acutely increase hepatic lipid accumulation over 24 to 72 hours. A 2017 controlled feeding trial in the Journal of Hepatology showed that just seven days of a high-fructose diet raised ALT and AST by a mean of 7 to 11 U/L in healthy adults. A single indulgent weekend can nudge your AST into the flagged range before a Monday blood draw. Always let your clinician know about any dietary extremes in the 72 hours before testing.
Exercise, Muscle, and False AST Elevations in Active Women
This is one of the most common sources of confusion for women who exercise regularly. AST is not exclusively a liver enzyme. Skeletal muscle is a major source, which means that a hard leg-day workout, a long run, or a HIIT session can raise your AST for 24 to 72 hours purely from muscle breakdown, with no liver involvement at all.
A practical framework for interpreting AST in active women:
| Scenario | AST pattern | ALT pattern | CK (creatine kinase) | Interpretation | |---|---|---|---|---| | Post-exercise (24 to 48 h) | Elevated | Normal or mildly elevated | Elevated | Muscle source, not liver | | NAFLD / metabolic liver | Mildly elevated | Elevated (ALT > AST) | Normal | Hepatic source | | Alcoholic hepatitis | Elevated | Elevated (AST > ALT, ratio >2) | Normal | Hepatic + mitochondrial | | Thyroid disease | Mildly elevated | Mildly elevated | May be elevated | Systemic metabolic |
If your AST is elevated and your clinician has not checked a CK (creatine kinase) or LDH alongside it, ask for those values. A markedly elevated CK with only a modest AST rise almost always points to muscle, not liver. The 2022 American College of Gastroenterology guideline on elevated liver chemistries explicitly recommends excluding vigorous exercise as a confounder before pursuing liver workup.
To get a clean AST that reflects hepatic function, avoid strenuous exercise for at least 48 hours before your blood draw.
Nutrition Factors That Move AST: A Women's Guide
Alcohol
Even moderate alcohol consumption raises AST in a dose-dependent way. The threshold is lower for women than for men. Women have less gastric alcohol dehydrogenase activity, meaning a larger fraction of each drink reaches the liver unchanged. ACOG Practice Bulletin guidance and CDC data consistently note that hepatic injury from alcohol occurs at lower consumption levels in women than in men. Two drinks the night before your lab draw can raise AST by 5 to 15 U/L.
If you drink at all, abstain for at least 48 hours before liver enzyme testing.
Fructose and Ultra-Processed Foods
Dietary fructose is metabolized almost exclusively in the liver, and excess intake drives de novo lipogenesis, hepatic steatosis, and enzyme release. The 2017 Journal of Hepatology fructose feeding trial noted above is one of the cleaner demonstrations of this effect. Women with PCOS appear particularly susceptible because fructose-driven lipogenesis compounds existing insulin-resistance-related hepatic fat accumulation.
Supplements and Herbal Products
This category is responsible for a large and underappreciated share of elevated AST readings in women. The Drug-Induced Liver Injury Network (DILIN) found that herbal and dietary supplements accounted for approximately 20 percent of hepatotoxicity cases in the US, and women are more likely than men to use these products. Common offenders include:
- High-dose vitamin A or beta-carotene supplements (chronic use above 10,000 IU/day)
- Green tea extract (EGCG) at doses above 800 mg/day
- Kava kava
- Black cohosh (relevant for women managing menopause symptoms)
- High-dose niacin (above 1,500 mg/day)
- Protein powders containing proprietary blends with unverified botanicals
Always list every supplement on your intake form before a lab panel. Black cohosh is particularly worth flagging: it is used by a meaningful proportion of perimenopausal women for hot flash relief, and a 2011 case series in Menopause documented hepatotoxicity in women using standardized black cohosh extracts, with AST and ALT rising to several times the upper limit of normal.
Protein Intake and Amino Acid Metabolism
High protein intake itself does not damage a healthy liver, but AST is a transaminase involved in amino acid metabolism, so very high-protein diets can modestly increase baseline AST values through increased enzymatic activity rather than hepatocyte damage. This matters if you are a woman doing strength training and eating 1.8 to 2.5 g of protein per kilogram of body weight: your AST could sit at the higher end of normal for metabolic reasons that have nothing to do with liver injury.
Women-Specific Physiology: How Hormones Change Your AST
Menstrual Cycle Variation
AST shows modest but measurable variation across the menstrual cycle. A small 2003 study in Clinical Chemistry and Laboratory Medicine found that liver enzymes, including AST, tended to be slightly lower in the follicular phase and slightly higher in the luteal phase, likely related to progesterone's effects on hepatic metabolism. The variation is small (roughly 2 to 5 U/L) but enough to matter if your result sits right at the threshold. Standardizing blood draws to a consistent cycle phase improves longitudinal tracking.
Oral Contraceptives and Exogenous Estrogen
Estrogen-containing contraceptives and menopausal hormone therapy (MHT) have a well-documented effect on liver enzyme metabolism. Combined oral contraceptives generally lower AST modestly and can impair the liver's ability to clear cholestatic compounds, which is why some women develop intrahepatic cholestasis of pregnancy (ICP) with an underlying susceptibility that oral contraceptives may have hinted at. If you recently started or stopped hormonal contraception, that context belongs in your lab interpretation.
PCOS and Metabolic Liver Disease
Women with PCOS have a prevalence of NAFLD estimated between 30 and 55 percent, substantially higher than age-matched women without PCOS. Insulin resistance drives hepatic lipid accumulation even when body weight is in the normal range. This means that if you have PCOS and your AST is 28 to 35 U/L, that result deserves more attention than it might get in a standard clinical workflow. Pairing AST with ALT, fasting insulin, and a fasting lipid panel gives a far more complete picture.
Perimenopause and Post-Menopause
The decline in estrogen during perimenopause is associated with increased visceral adiposity and worsening insulin resistance, both of which can drive hepatic steatosis and gradual AST elevation. A 2021 observational study in Menopause journal found that postmenopausal women had significantly higher rates of NAFLD compared to premenopausal women of similar BMI, and that menopausal hormone therapy was associated with a modestly lower prevalence of hepatic steatosis. If you are in perimenopause or post-menopause and your AST is creeping upward, a hepatic steatosis workup (liver ultrasound plus fasting insulin and lipids) is a reasonable next step.
Postpartum Period
The immediate postpartum period is a time of rapid hormonal flux. AST and ALT commonly normalize within six to eight weeks postpartum after elevations related to delivery, and breastfeeding has not been shown to significantly alter liver enzyme levels in healthy women.
AST in Pregnancy and Lactation
Pregnancy changes every organ system, and the liver is no exception.
Normal pregnancy: AST typically remains within the non-pregnant reference range through the first two trimesters. In the third trimester, modest elevation (up to 1.5 times the upper limit of normal) may reflect increased placental production. Alkaline phosphatase rises substantially in pregnancy due to placental isoenzyme and should not be used as a liver marker during this period.
HELLP syndrome: A markedly elevated AST in the second half of pregnancy, particularly when accompanied by low platelets and hemolysis, is a cardinal sign of HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome, a life-threatening obstetric emergency. ACOG Practice Bulletin No. 222 on gestational hypertension and preeclampsia defines severe HELLP as AST or ALT more than twice the upper limit of normal with platelet count below 100,000/microL. If you are pregnant and receive a report of elevated AST, this is not a "watch and repeat" situation. Contact your obstetric provider the same day.
Intrahepatic cholestasis of pregnancy (ICP): AST may be mildly to moderately elevated in ICP, a condition characterized by intense pruritus and bile acid elevation, which carries a risk of preterm birth and fetal distress. ACOG guidelines on ICP recommend ursodeoxycholic acid and fetal surveillance.
Acute fatty liver of pregnancy (AFLP): Rare but potentially fatal, AFLP causes AST to rise to hundreds or thousands of U/L in the third trimester. It requires immediate delivery.
Lactation: No dietary or lactation-related intervention is known to significantly alter AST in breastfeeding women outside of the usual confounders (alcohol, supplements, exercise). If a breastfeeding woman is prescribed a medication that carries hepatotoxicity risk, monitoring AST and ALT is appropriate, but standard lactation itself is not a liver stressor.
Who Should Get a Closer Look at Their AST
The following women warrant more proactive AST monitoring or a lower threshold for full hepatic workup:
- Women with PCOS, particularly those with insulin resistance or elevated triglycerides
- Perimenopausal and postmenopausal women with central adiposity
- Women taking hepatotoxic supplements (see list above) or long-term medications including methotrexate, statins, tamoxifen, or valproate
- Women who consume more than seven standard alcoholic drinks per week (the threshold for elevated hepatic risk in women per NIAAA guidance)
- Women with hypothyroidism, which can independently raise AST through increased CK
- Pregnant women in the second half of pregnancy with any new symptom, especially right upper quadrant pain, pruritus, or nausea
How to Get the Cleanest AST Result
Standardizing your pre-test conditions removes the noise and makes repeat values genuinely comparable over time.
- Fast for 10 to 12 hours (water is fine).
- Avoid strenuous exercise for 48 hours before the draw.
- Do not drink alcohol for at least 48 hours.
- Withhold any supplements you have not already disclosed to your clinician.
- If you menstruate regularly, consider standardizing your draw to the early follicular phase (days 2 to 5) for longitudinal tracking.
- Tell the phlebotomist or your clinician if you have had any high-fat or high-sugar meals in the past 72 hours, started or stopped hormonal contraception, or recently finished a prolonged fast.
These steps take nothing away from a routine annual lab visit. They simply give you numbers that are actually comparable from one year to the next.
Frequently asked questions
›What is the optimal AST range for women?
›Does fasting affect AST levels?
›Can exercise cause a falsely elevated AST?
›What is a dangerous AST level in pregnancy?
›How does PCOS affect AST?
›Which supplements raise AST in women?
›Does alcohol affect AST more in women than men?
›Can hormonal birth control affect my AST result?
›What does an AST:ALT ratio above 2 mean?
›How does menopause affect liver enzymes?
›Is a low AST ever a problem?
References
- Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1-10.
- Schreiner AD, Rockey DC. Evaluation of abnormal liver tests in the adult asymptomatic patient. Curr Opin Gastroenterol. 2018;34(4):272-279.
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease. Hepatology. 2016;64(1):73-84.
- Kang SH, Lee HW, Yoo JJ, et al. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2021;27(3):363-401.
- Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of physical exercise and relationship with biochemical variables of NT-pro-BNP and high-sensitivity troponin T. Clin Chem Lab Med. 2006;44(12):1557-1559.
- Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. Cell Metab. 2020;32(2):299-302.
- Volynets V, Machann J, Küper MA, et al. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease. J Hepatol. 2017;66(4):755-763.
- Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology. 1997;25(1):108-111.
- Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
- Sarkar M, Grab J, Dodge JL, et al. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. J Hepatol. 2020;73(3):516-522.
- ACOG Practice Bulletin No. 222: Gestational hypertension and preeclampsia. Obstet Gynecol. 2020;135(6):e237-e260.
- ACOG Practice Bulletin on intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2021;138(4):e80-e91.
- Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363-373.
- Piton A, Poynard T, Imbert-Bismut F, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology. 1998;27(5):1213-1219.
- Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18-35.
- National Institute on Alcohol Abuse and Alcoholism. Women and alcohol. NIAAA Fact Sheet. 2022.
- National Library of Medicine. Aspartate aminotransferase (AST). StatPearls. 2023.
- Centers for Disease Control and Prevention. Women and drinking. CDC Fact Sheet. 2022.
- ACOG Committee Opinion: At-risk drinking and alcohol dependence. Obstet Gynecol. 2011;118(2 Pt 1):383-388.